List of Tables
Table 1. Global Safety Lancets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Safety Lancets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Safety Lancets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Safety Lancets Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Safety Lancets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Safety Lancets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Safety Lancets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Safety Lancets Average Price (US$/K Units) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Safety Lancets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Safety Lancets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Safety Lancets, Product Types and Applications
Table 12. Global Key Manufacturers of Safety Lancets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Safety Lancets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Safety Lancets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Safety Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Safety Lancets Sales by Region (M Units), 2021–2026
Table 18. Global Safety Lancets Sales Market Share by Region (2021–2026)
Table 19. Global Safety Lancets Sales by Region (M Units), 2027–2032
Table 20. Global Safety Lancets Sales Market Share by Region (2027–2032)
Table 21. Global Safety Lancets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Safety Lancets Revenue Market Share by Region (2021–2026)
Table 23. Global Safety Lancets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Safety Lancets Revenue Market Share by Region (2027–2032)
Table 25. North America Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Safety Lancets Sales by Country (M Units), 2021–2026
Table 27. North America Safety Lancets Sales by Country (M Units), 2027–2032
Table 28. North America Safety Lancets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Safety Lancets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Safety Lancets Sales by Country (M Units), 2021–2026
Table 32. Europe Safety Lancets Sales by Country (M Units), 2027–2032
Table 33. Europe Safety Lancets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Safety Lancets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Safety Lancets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Safety Lancets Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Safety Lancets Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Safety Lancets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Safety Lancets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Safety Lancets Sales by Country (M Units), 2021–2026
Table 42. Latin America Safety Lancets Sales by Country (M Units), 2027–2032
Table 43. Latin America Safety Lancets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Safety Lancets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Safety Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Safety Lancets Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Safety Lancets Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Safety Lancets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Safety Lancets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Safety Lancets Sales (M Units) by Type (2021–2026)
Table 51. Global Safety Lancets Sales (M Units) by Type (2027–2032)
Table 52. Global Safety Lancets Sales Market Share by Type (2021–2026)
Table 53. Global Safety Lancets Sales Market Share by Type (2027–2032)
Table 54. Global Safety Lancets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Safety Lancets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Safety Lancets Revenue Market Share by Type (2021–2026)
Table 57. Global Safety Lancets Revenue Market Share by Type (2027–2032)
Table 58. Global Safety Lancets Price (US$/K Units) by Type (2021–2026)
Table 59. Global Safety Lancets Price (US$/K Units) by Type (2027–2032)
Table 60. Global Safety Lancets Sales (M Units) by Application (2021–2026)
Table 61. Global Safety Lancets Sales (M Units) by Application (2027–2032)
Table 62. Global Safety Lancets Sales Market Share by Application (2021–2026)
Table 63. Global Safety Lancets Sales Market Share by Application (2027–2032)
Table 64. Global Safety Lancets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Safety Lancets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Safety Lancets Revenue Market Share by Application (2021–2026)
Table 67. Global Safety Lancets Revenue Market Share by Application (2027–2032)
Table 68. Global Safety Lancets Price (US$/K Units) by Application (2021–2026)
Table 69. Global Safety Lancets Price (US$/K Units) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 73. Roche Safety Lancets Product
Table 74. Roche Recent Developments/Updates
Table 75. BD Company Information
Table 76. BD Description and Business Overview
Table 77. BD Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 78. BD Safety Lancets Product
Table 79. BD Recent Developments/Updates
Table 80. Ascensia Company Information
Table 81. Ascensia Description and Business Overview
Table 82. Ascensia Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 83. Ascensia Safety Lancets Product
Table 84. Ascensia Recent Developments/Updates
Table 85. Lifescan Company Information
Table 86. Lifescan Description and Business Overview
Table 87. Lifescan Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 88. Lifescan Safety Lancets Product
Table 89. Lifescan Recent Developments/Updates
Table 90. B. Braun Company Information
Table 91. B. Braun Description and Business Overview
Table 92. B. Braun Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 93. B. Braun Safety Lancets Product
Table 94. B. Braun Recent Developments/Updates
Table 95. Terumo Company Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 98. Terumo Safety Lancets Product
Table 99. Terumo Recent Developments/Updates
Table 100. Nipro Company Information
Table 101. Nipro Description and Business Overview
Table 102. Nipro Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 103. Nipro Safety Lancets Product
Table 104. Nipro Recent Developments/Updates
Table 105. Cardinal Health Company Information
Table 106. Cardinal Health Description and Business Overview
Table 107. Cardinal Health Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 108. Cardinal Health Safety Lancets Product
Table 109. Cardinal Health Recent Developments/Updates
Table 110. ARKRAY Company Information
Table 111. ARKRAY Description and Business Overview
Table 112. ARKRAY Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 113. ARKRAY Safety Lancets Product
Table 114. ARKRAY Recent Developments/Updates
Table 115. ICU Medical Company Information
Table 116. ICU Medical Description and Business Overview
Table 117. ICU Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 118. ICU Medical Safety Lancets Product
Table 119. ICU Medical Recent Developments/Updates
Table 120. Owen Mumford Company Information
Table 121. Owen Mumford Description and Business Overview
Table 122. Owen Mumford Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 123. Owen Mumford Safety Lancets Product
Table 124. Owen Mumford Recent Developments/Updates
Table 125. HemoCue Company Information
Table 126. HemoCue Description and Business Overview
Table 127. HemoCue Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 128. HemoCue Safety Lancets Product
Table 129. HemoCue Recent Developments/Updates
Table 130. Greiner Bio One Company Information
Table 131. Greiner Bio One Description and Business Overview
Table 132. Greiner Bio One Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 133. Greiner Bio One Safety Lancets Product
Table 134. Greiner Bio One Recent Developments/Updates
Table 135. HTL-STREFA Company Information
Table 136. HTL-STREFA Description and Business Overview
Table 137. HTL-STREFA Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 138. HTL-STREFA Safety Lancets Product
Table 139. HTL-STREFA Recent Developments/Updates
Table 140. Sarstedt Company Information
Table 141. Sarstedt Description and Business Overview
Table 142. Sarstedt Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 143. Sarstedt Safety Lancets Product
Table 144. Sarstedt Recent Developments/Updates
Table 145. UltiMed Company Information
Table 146. UltiMed Description and Business Overview
Table 147. UltiMed Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 148. UltiMed Safety Lancets Product
Table 149. UltiMed Recent Developments/Updates
Table 150. Tianjin Huahong Company Information
Table 151. Tianjin Huahong Description and Business Overview
Table 152. Tianjin Huahong Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 153. Tianjin Huahong Safety Lancets Product
Table 154. Tianjin Huahong Recent Developments/Updates
Table 155. Guangzhou iCare Medical Company Information
Table 156. Guangzhou iCare Medical Description and Business Overview
Table 157. Guangzhou iCare Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 158. Guangzhou iCare Medical Safety Lancets Product
Table 159. Guangzhou iCare Medical Recent Developments/Updates
Table 160. Shandong Lianfa Company Information
Table 161. Shandong Lianfa Description and Business Overview
Table 162. Shandong Lianfa Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 163. Shandong Lianfa Safety Lancets Product
Table 164. Shandong Lianfa Recent Developments/Updates
Table 165. SteriLance Medical Company Information
Table 166. SteriLance Medical Description and Business Overview
Table 167. SteriLance Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
Table 168. SteriLance Medical Safety Lancets Product
Table 169. SteriLance Medical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Safety Lancets Distributors List
Table 173. Safety Lancets Customers List
Table 174. Safety Lancets Market Trends
Table 175. Safety Lancets Market Drivers
Table 176. Safety Lancets Market Challenges
Table 177. Safety Lancets Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Safety Lancets
Figure 2. Global Safety Lancets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Safety Lancets Market Share by Type: 2025 & 2032
Figure 4. Safety Lancets with Needle Product Picture
Figure 5. Safety Lancets with Blade Product Picture
Figure 6. Global Safety Lancets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Safety Lancets Market Share by Application: 2025 & 2032
Figure 8. Hospital & Clinics
Figure 9. Home
Figure 10. Other
Figure 11. Global Safety Lancets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Safety Lancets Market Size (US$ Million), 2021–2032
Figure 13. Global Safety Lancets Sales (M Units), 2021–2032
Figure 14. Global Safety Lancets Average Price (US$/K Units), 2021–2032
Figure 15. Safety Lancets Report Years Considered
Figure 16. Safety Lancets Sales Share by Manufacturers in 2025
Figure 17. Global Safety Lancets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Safety Lancets Players: Market Share by Revenue in Safety Lancets in 2025
Figure 19. Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Safety Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Safety Lancets Sales Market Share by Country (2021–2032)
Figure 22. North America Safety Lancets Revenue Market Share by Country (2021–2032)
Figure 23. United States Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Safety Lancets Sales Market Share by Country (2021–2032)
Figure 26. Europe Safety Lancets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Safety Lancets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Safety Lancets Revenue Market Share by Region (2021–2032)
Figure 34. China Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Safety Lancets Sales Market Share by Country (2021–2032)
Figure 45. Latin America Safety Lancets Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Safety Lancets Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Safety Lancets Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Safety Lancets Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Safety Lancets by Type (2021–2032)
Figure 55. Global Revenue Market Share of Safety Lancets by Type (2021–2032)
Figure 56. Global Safety Lancets Price (US$/K Units) by Type (2021–2032)
Figure 57. Global Sales Market Share of Safety Lancets by Application (2021–2032)
Figure 58. Global Revenue Market Share of Safety Lancets by Application (2021–2032)
Figure 59. Global Safety Lancets Price (US$/K Units) by Application (2021–2032)
Figure 60. Safety Lancets Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
